152 153 Intestinal Disease Meeting Berlin 2006 - Dr. Falk Pharma ...
152 153 Intestinal Disease Meeting Berlin 2006 - Dr. Falk Pharma ...
152 153 Intestinal Disease Meeting Berlin 2006 - Dr. Falk Pharma ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Session 5<br />
Prevention and Management<br />
of Complications<br />
Chair:<br />
F. Schreiber, Graz<br />
P.A. Testoni, Milan<br />
20<br />
Endoscopic procedures are associated<br />
with low overall mortality<br />
The overall mortality associated with diagnostic<br />
endoscopic procedures is reported as 0.3–0.5<br />
per 1000 procedures, of which about 50% of<br />
deaths are due to cardiopulmonary complications,<br />
the majority of which develop as a result<br />
of pre-medication. “The risks of endoscopic<br />
procedures are overall very low,” said M. Jung<br />
(Mainz).<br />
In his opinion, it is important to consider the<br />
dangers of premedication. It is common practice<br />
before a procedure to administer a short-acting<br />
benzodiazepine either alone or in combination<br />
with an opiate. Most commonly used agents are<br />
midazolam or propofol. Both agents are characterized<br />
by a short elimination half-life and corresponding<br />
short duration of action. Propofol has<br />
advantages over benzodiazepines, especially<br />
because patients recover very quickly from the<br />
medication.<br />
M. Jung W. Schmitt<br />
Propofol: Does an anesthesiologist<br />
need to be present?<br />
On the other hand, this hypnotic agent induces<br />
a certain amount of cardiac and respiratory depression<br />
and there is no antagonist that can be<br />
administered if the situation becomes critical.<br />
Nevertheless, M. Jung does not consider justified<br />
those recommendations that propofol be used<br />
only in the presence of an anesthesiologist. Experience<br />
to date suggests that, with the proper<br />
training, this agent can be safely used in patients<br />
undergoing endoscopic interventions.<br />
Low rate of complications<br />
associated with polypectomy<br />
The rate of complications is also comparatively<br />
low with polypectomy, explained W. Schmitt<br />
(Munich). Overall morbidity stands at 0.36–4.8%,<br />
of which bleeding makes up 0.6–3.4% of cases.<br />
In second place are perforations at 0.08–0.83%.<br />
Mortality associated with the procedure is reported<br />
as 0.006–0.03%.<br />
Under discussion is the question of prophylactic<br />
clipping as a means of reducing the risk of<br />
bleeding. “Convincing data supporting its use<br />
have yet to be published,” said W. Schmitt. If<br />
bleeding does occur, it can be treated with sclerotherapy,<br />
clipping or by means of coagulation.